SecondWave Systems occupies a distinctive position in the bioelectronic medicine space by applying wearable, non-invasive focused ultrasound to anti-inflammatory neural pathways — a modality and delivery method that differs from both implantable VNS devices and conventional transcutaneous neuromodulation. Its government funding base and JLABS membership suggest early institutional validation, though clinical proof of durable anti-inflammatory efficacy will be required before it can challenge pharmacological biologics.